Octatropine-methyl-bromide and sulglycotide salt in the short-term treatment of active duodenal ulcer. A double blind endoscopic study of 40 outpatients.

Forty outpatients with endoscopically confirmed duodenal ulcers were entered in a double blind trial. They were randomly allocated to octatropine-methyl-bromide and sulglycotide salt (GVP) or placebo. The results show that the combination of the two drugs is less efficacious than the two constituent substances taken separately, is not more efficacious than placebo in ulcer healing, and is ineffective with regard to ulcer pain.
AuthorsG Dobrilla, M Valentini, M C Bonoldi, L Piazzi
JournalScandinavian journal of gastroenterology. Supplement (Scand J Gastroenterol Suppl) Vol. 167 Pg. 65-7 ( 1989) ISSN: 0085-5928 [Print] NORWAY
PMID2694331 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Ulcer Agents
  • Drug Combinations
  • Parasympatholytics
  • Sialoglycoproteins
  • Tropanes
  • GVP anti-ulcer agent
  • sulglicotide
  • octotropine methylbromide
  • Anti-Ulcer Agents (therapeutic use)
  • Double-Blind Method
  • Drug Combinations (therapeutic use)
  • Duodenal Ulcer (drug therapy)
  • Humans
  • Parasympatholytics (therapeutic use)
  • Randomized Controlled Trials as Topic
  • Sialoglycoproteins (therapeutic use)
  • Time Factors
  • Tropanes (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: